Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
News and Views

Pharmaceutical Technology


Atlas Hires Senior Technical Consultant

Atlas Material Testing Technology (Chicago, IL, http://www.atlas-mts.com/) named David Dumbleton its senior technical consultant for the newly created Atlas Consulting Group. Dumbleton will lend his expertise in environmental durability and performance to Atlas's customers and expand the North American consultingservices group.

Dumbleton's experience includes technical and business management in the polymer-materials industry. He previously worked as a director of research and development at Alcoa Flexible Packaging.

Expansions

BASF Adds THF Capacity at Ludwigshafen Site

BASF (Florham Park, NJ http://www.basf.com/) is expanding its annual capacity for the intermediate tetrahydrofuran (THF) by 30, 000 tons at its Ludwigshafen site. The expansion will raise the company's annual THF capacity to 210, 000 metric tons by the end of 2007.

THF is used in complex water-sensitive reactions frequently needed to produce active pharmaceutical ingredients. BASF supplies high-purity THF with a low residual water content of 0.01%.

Future Pak Moves to Larger Facility

Future Pak Ltd. (Wixom, MI, http://www.futurepak.com/), a contract packager, moved its solid-dose packaging operations to a new location. Three blister suites, 12 form–fill–seal lines, and soliddose bottling operations moved to a 32, 000-ft2 facility in Wixom, Michigan.

The site will provide space for the expansion of the company's blister-packaging capacity. During the past three years, Future Pak's annual packaging volume grew to 1800 batches, or about 7 billion tablets.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: Pharmaceutical Technology,
Click here